Sequence Review

Sequence — Provider Profile

Overview

Sequence positions itself as the "clinical-first" GLP-1 telehealth provider. Founded by obesity medicine specialists, the platform emphasizes board-certified clinicians, insurance-first prescribing, and a medically rigorous approach compared to most direct-to-consumer competitors. Their model prioritizes getting patients onto brand-name FDA-approved medications through insurance rather than defaulting to compounded alternatives.

April 2026 context: This provider is active and prescribing brand-name GLP-1 medications. Orforglipron (Eli Lilly oral GLP-1) is not yet FDA-approved — PDUFA date April 10, 2026. Medicare GLP-1 Bridge coverage for obesity is pending; not yet in effect. Compounded semaglutide supply is declining under FDA enforcement pressure.

Pricing and protocol data sourced from this provider's public website, verified April 2026. Patient experience data from verified patient reports. We have no commercial relationship with this provider.

Medications Offered

• Brand Wegovy (semaglutide) — FDA-approved; insurance-first approach with prior authorization support
• Brand Zepbound (tirzepatide) — Dual GIP/GLP-1 receptor agonist; pursued through insurance first
• Brand Saxenda (liraglutide) — Older GLP-1 option, sometimes easier to get insurance approval
• Wegovy HD (7.2mg semaglutide) — Higher-dose formulation for patients needing additional weight loss
• Orforglipron — Oral GLP-1, $149/mo cash-pay

Pricing

Pricing last verified April 2026. Confirm current pricing directly with the provider before enrolling.

Sequence's model is insurance-first. The $99/month membership covers the clinical team, and medication costs depend on your insurance coverage. Total monthly cost can range from ~$99 + small copay (with good insurance) to $248/mo (once orforglipron is approved and available — PDUFA April 10, 2026). Compounded options are no longer available.

States Served

Available in most US states. Check Sequence's website for current availability. Coverage is expanding.

Insurance

• Membership: Cash-pay ($99/month), not billed through insurance
• Medication: Sequence specializes in getting patients approved for brand-name GLP-1 medications through insurance. Their clinical team handles prior authorizations and appeals — this is a core differentiator. Many patients successfully get Wegovy or Zepbound covered through their plan.

Consultation Process

Model: Video consultations with board-certified clinicians, many specializing in obesity medicine or endocrinology.

1. Complete a detailed medical history intake covering comorbidities, prior weight loss attempts, and metabolic health indicators
2. One-on-one video consultation with a board-certified clinician for a real clinical evaluation (not a questionnaire rubber-stamp)
3. Insurance navigation — Sequence works to get you approved for brand-name GLP-1 medications
4. Personalized titration schedule based on your response and tolerability
5. Regular video follow-ups (typically monthly), lab work recommendations, and metabolic health tracking through the Sequence app

Clinical Protocol

Protocol transparency note: Protocol details represent publicly available provider information verified April 2026. Individual treatment plans may differ based on clinical judgment. Verify current protocols directly with the provider before starting treatment.

Titration Notes

Sequence's insurance-first model means many patients access brand-name Wegovy or Zepbound with personalized titration oversight rather than compounded alternatives. Compounded options are no longer available. Titration decisions are made during video visits based on clinical response and tolerability.

What to Expect Clinically

Monthly video visits initially, app-based tracking, and personalized titration oversight. Lab work is recommended and reviewed during consultations but is not included in the base membership cost. Integration with the WeightWatchers behavioral program is available alongside the clinical track.

Pros

• Founded by obesity medicine specialists — deep clinical expertise baked into the model
• Insurance-first approach can save patients hundreds per month on brand-name GLP-1 medications
• Video consultations with experienced clinicians, not just questionnaire-based async reviews
• Prior authorization and insurance appeals support included in membership
• Personalized titration managed through follow-up video visits

Cons

• Higher total cost for cash-pay patients — $99 membership + $149 orforglipron = $248/month
• The $99/month membership is charged on top of medication costs (unlike all-inclusive platforms)
• No published independent outcomes data for their patient population
• Insurance navigation success varies — coverage is not guaranteed
• Less established brand than Hims or Ro

Best For

Patients with health insurance that may cover GLP-1 medications. Sequence's insurance navigation expertise is their biggest value-add — if your plan covers Wegovy or Zepbound, your total cost could be just $99/month plus a copay, which is exceptional value for specialist-level care. Also strong for patients who want a clinically rigorous, video-based experience closer to a traditional obesity medicine practice.

Editorial Verdict

Sequence offers the most insurance-savvy GLP-1 telehealth experience we've seen. If you have insurance that might cover weight loss medications, Sequence's prior authorization expertise could save you hundreds per month compared to paying cash for compounded alternatives. The clinical depth — video visits with obesity medicine specialists, personalized titration, ongoing monitoring — is closer to a traditional medical practice than most telehealth platforms.

The downside is cost structure. For cash-pay patients, the two-part billing (membership + orforglipron) adds up to $248/month. Sequence is most compelling when insurance is in play — the $99 membership plus a Medicare Bridge $50/mo copay is strong value. For a head-to-head with a behavioral coaching alternative, read our Noom vs Sequence weight loss comparison.

Data Sources

Pricing and protocol information sourced from Sequence's official website (verified April 2026). Consultation process details sourced from provider onboarding flow documentation. Patient experience descriptions sourced from public patient reviews. Telehealth Ally has no affiliate or commercial relationship with this provider.

Related Content

• Full Sequence Weight Loss Review — Our in-depth analysis
• Noom vs Sequence — Which program fits your needs?
• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• GLP-1 Prior Authorization Guide — Getting insurance approval
• GLP-1 Cost & Insurance FAQ — What you'll actually pay

Sequence Weight Loss Review 2026: Pricing, How It Works, and Who It's Best For

Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.

Sequence positions itself as the "clinical-first" GLP-1 telehealth provider. Founded by obesity medicine specialists, the platform emphasizes board-certified clinicians, insurance-first prescribing, and a more medically rigorous approach than most direct-to-consumer competitors. Their model prioritizes getting patients onto brand-name FDA-approved medications through insurance rather than defaulting to compounded alternatives.

If you want a telehealth provider that feels closer to a traditional obesity medicine practice — but delivered digitally — Sequence is worth evaluating. This review covers pricing, how their program works, what sets them apart, and who should consider them.

How does Sequence weight loss work?

Sequence follows a more clinical model than most telehealth GLP-1 providers. Every patient gets a live video consultation with a board-certified obesity medicine specialist before prescribing — not a questionnaire review.

1. Online intake — Complete a detailed medical history questionnaire including current medications, comorbidities, prior weight loss attempts, and metabolic health indicators.
2. Video consultation — A one-on-one video visit with a board-certified clinician (many are obesity medicine specialists or endocrinologists). This is a real clinical evaluation, not a rubber-stamp questionnaire review.
3. Insurance navigation — Sequence actively works to get patients approved for brand-name GLP-1 medications through their insurance. This includes prior authorization support and appeals assistance.
4. Prescription and titration — Your clinician develops a personalized titration schedule based on your response and tolerability. Dose adjustments are made through follow-up video visits, not just messaging.
5. Ongoing monitoring — Regular video check-ins (typically monthly), lab work recommendations, and metabolic health tracking through the Sequence app.

Pricing last verified April 2026. We update pricing data monthly. Contact us if you spot an error.

How much does Sequence cost per month?

Sequence charges $99/month for membership, which covers board-certified clinician visits and care coordination. Medication cost depends on your insurance — insured patients may pay only a copay; cash-pay patients pay $199–$349/month for compounded medications. All-in, insured patients may pay as little as $99/month plus a small copay; cash-pay patients should expect $299–$449/month total.

Sequence's model is insurance-first. The $99/month membership covers the clinical team, and medication costs depend on your insurance coverage. For patients without GLP-1 insurance coverage, Sequence offers compounded alternatives but positions them as a fallback, not the default.

Important note: The total monthly cost varies significantly based on your insurance. Patients with good GLP-1 coverage may pay $99/mo + a small copay. Patients paying cash for compounded medication could pay $299-$449/mo total.

What medications does Sequence offer?

Sequence primarily pursues brand-name FDA-approved medications through insurance before falling back to compounded options.

• Brand Wegovy (semaglutide) — FDA-approved, insurance-first approach. Sequence specializes in getting prior authorizations approved.
• Brand Zepbound (tirzepatide) — Dual GIP/GLP-1 receptor agonist. Also pursued through insurance first.
• Brand Saxenda (liraglutide) — Older GLP-1 option, sometimes easier to get insurance approval for.
• Compounded semaglutide — Available as a cash-pay fallback when insurance doesn't cover brand-name options.
• Compounded tirzepatide — Available as a cash-pay alternative to brand Zepbound.

Sequence's clinicians may also address adjacent metabolic health issues and coordinate with your primary care physician.

How effective is Sequence's program?

Sequence primarily prescribes FDA-approved medications with robust clinical trial data. Board-certified specialist oversight and video-first follow-up may improve adherence and clinical outcomes compared to async-only platforms.

• Wegovy (semaglutide 2.4mg): STEP 1 trial showed 14.9% average body weight loss over 68 weeks.
• Zepbound (tirzepatide): SURMOUNT-1 trial showed up to 22.5% average body weight loss at the highest dose over 72 weeks.

Sequence's added value is the clinical expertise in managing titration, side effects, and treatment modifications — which may improve adherence and outcomes compared to async-only platforms. However, Sequence has not published independent outcomes data for their specific patient population. We'd like to see this.

What are the pros of Sequence?

• Clinical rigor — Board-certified obesity medicine specialists and endocrinologists, not just general practitioners reviewing questionnaires.
• Insurance-first model — Actively works to get patients on brand-name, FDA-approved medications through insurance, which can be significantly cheaper than cash-pay compounded options long-term.
• Video consultations standard — Every patient gets real face-time with their clinician. Dose adjustments happen through clinical conversations, not automated messaging.
• Prior authorization expertise — Sequence's team handles the insurance bureaucracy that most patients find overwhelming.
• Personalized titration — Dosing schedules tailored to individual response and tolerability, not one-size-fits-all protocols.

What are the cons of Sequence?

• Higher base cost — The $99/month membership fee is on top of medication costs. If your insurance covers the medication, this is reasonable. If you're paying cash for everything, the total cost can be $300-$450/month.
• Insurance dependency — The value proposition is strongest for patients with insurance that covers GLP-1 medications. Without coverage, you're paying a premium membership fee on top of compounded medication costs.
• Slower onboarding — The insurance-first approach means prior authorizations, which can take 1-3 weeks. Patients wanting to start immediately may prefer direct-to-consumer compounded options.
• Smaller provider network — Sequence is newer and smaller than Ro or Hims. Availability may vary by state.
• No integrated coaching or nutrition program — Unlike Noom or Calibrate, Sequence focuses on the medical side without a structured behavioral change curriculum.

Who is Sequence best for?

• Patients with insurance that may cover GLP-1 medications — Sequence's prior auth expertise can save thousands annually compared to cash-pay
• Patients who want a clinically rigorous approach — Board-certified obesity medicine specialists, not general telehealth practitioners
• People with complex medical histories — The video-first, specialist-led model is better equipped for patients with comorbidities
• Patients who prefer brand-name FDA-approved medications over compounded formulations

Who should look elsewhere?

• Budget-conscious patients without GLP-1 insurance coverage — Ro or Hims offer compounded semaglutide at lower total monthly costs. Patients asking how to get GLP-1 without insurance at the lowest possible price should start with Ro ($149/mo) rather than Sequence.
• Patients wanting immediate access — The insurance-first model means a longer time to first dose
• People who want integrated behavioral coaching — Consider Noom Med or Calibrate
• Patients in states where Sequence doesn't yet operate — Check availability before starting the intake process

Is Sequence worth it?

Sequence is the telehealth GLP-1 provider that most closely resembles a traditional obesity medicine practice. Their board-certified specialists, insurance-first approach, and video consultation model provide a level of clinical rigor that async-only platforms simply cannot match. The tradeoff is cost and speed: the membership fee adds up, and the insurance navigation process takes time.

For patients with insurance that covers GLP-1 medications, Sequence is arguably one of the best online GLP-1 programs on the market — you get specialist-level care and brand-name medications for $99/month plus your copay. Whether Sequence is worth it for cash-pay patients is a harder question: at $299–$449/month total, the math is less compelling compared to Ro's $149/month compounded semaglutide.

Rating: 4.2/5

Frequently Asked Questions

Is Sequence legit? Yes. Sequence is a legitimate telehealth platform founded by obesity medicine specialists. It operates with board-certified physicians and endocrinologists. The insurance-first model makes it particularly credible for patients who want brand-name medications with appropriate clinical oversight.

How much does Sequence cost per month? $99/month membership fee covers all clinical services. Medication cost depends on insurance — insured patients pay their copay; cash-pay patients add $199–$349/month for compounded medications. Total range: $99/month (insured with good coverage) to $449/month (cash-pay with tirzepatide).

Does Sequence take insurance? Yes. Sequence's core model is insurance-first — they actively pursue prior authorizations for brand-name GLP-1 medications and handle appeals assistance. This is a stronger insurance navigation service than most telehealth competitors offer.

How long does Sequence take to get medication? Longer than async platforms. The insurance navigation process typically takes 1–3 weeks for prior authorization. Patients who want to start medication immediately should consider Ro or Henry Meds as faster alternatives.

Does Sequence offer compounded semaglutide? Yes, as a cash-pay fallback when insurance doesn't cover brand-name options. Sequence's preference is brand-name medications through insurance; compounded options are available for patients without coverage.

How does Sequence compare to Calibrate? Both are insurance-focused, clinically rigorous platforms. Calibrate includes lab panels and a structured behavioral curriculum — Sequence does not. Sequence's $99/month membership is lower than Calibrate's program fee, but Calibrate offers more comprehensive metabolic care. For patients who want specialist-led prescribing without a full behavioral program, Sequence is the better fit.

Data Sources & Methodology

Pricing and protocol data sourced from Sequence's public website and verified via checkout flow, April 2026. Patient experience data drawn from public reviews (Google, Trustpilot, Reddit) and independent patient outreach. Telehealth Ally has no commercial relationship with this provider. Rankings and ratings are editorial-only.

Related Resources

• Sequence Provider Profile — Medications, pricing, and consultation details
• Noom vs Sequence Comparison — Which program fits your needs?
• Best GLP-1 Weight Loss Programs 2026 — All major providers ranked
• GLP-1 Prior Authorization Guide — Getting insurance to cover your treatment
• GLP-1 Cost & Insurance FAQ — What you'll actually pay